Abstract BAP1 and HMGB1 alterations are implicated in the pathogenesis of mesothelioma, an aggressive cancer of the membranes covering the thoracic and abdominal cavities. Genetic
Sound preclinical mechanistic study demonstrating that EGFR deletion in myeloid cells sensitizes CRC metastases to anti-PD-L1 immunotherapy, with supporting RNA-seq data and clinical survival association, but limited by syngeneic model and lack of human trial data.